Pionorm 15 mg Tablet

Initiate pioglitazone tablets at 15 mg or 30 mg once daily. Limit initial dose to 15 mg once daily in patients with NYHA Class I or II heart failure., If there is inadequate glycemic control, the dose can be increased in 15 mg increments up to a maximum of 45 mg once daily., Obtain liver tests before starting pioglitazone tablets. If abnormal, use caution when treating with pioglitazone tablets, investigate the probable cause, treat (if possible) and follow appropriately.

Directions from the U.S. FDA-approved label for Pioglitazone — your doctor or pharmacist may advise differently.

Initiation in patients with established NYHA Class III or IV heart failure., Use in patients with known hypersensitivity to pioglitazone or any other component of pioglitazone tablets., Initiation in patients with established New York Heart Association (NYHA) Class III or IV heart failure., Use in patients with known hypersensitivity to pioglitazone or any other component of pioglitazone tablets.

Excerpt from the U.S. FDA-approved label for Pioglitazone. Talk to a pharmacist or doctor before use.

Congestive heart failure: Fluid retention may occur and can exacerbate or lead to congestive heart failure. Combination use with insulin and use in congestive heart failure NYHA Class I and II may increase risk. Monitor patients for signs and symptoms., Hypoglycemia: When used with insulin or an insulin secretagogue, a lower dose of the insulin or insulin secretagogue may be needed to reduce the risk of hypoglycemia., Hepatic effects: Postmarketing reports of hepatic failure, sometimes fatal. Causality cannot be excluded.

Warnings and precautions excerpt from the U.S. FDA-approved label for Pioglitazone — not a complete list. Talk to a pharmacist or doctor before use.

The following serious adverse reactions are discussed elsewhere in the labeling: Congestive heart failure, Edema, Fractures Most common adverse reactions (≥5%) are upper respiratory tract infection, headache, sinusitis, myalgia, and pharyngitis. To report SUSPECTED ADVERSE REACTIONS, contact Solco Healthcare LLC at 1-866-257-2597 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Excerpt from the U.S. FDA-approved label for Pioglitazone — not a complete list. Talk to a pharmacist or doctor about side effects.

33 brands · 16 makers in the NepalDoc catalog — see the full Pioglitazone guide →

Keep container tightly closed, and protect from light, moisture and humidity.

Storage information from the U.S. FDA-approved label for Pioglitazone.